FinTrust Capital Advisors’s Immunogen Inc IMGN Stock Holding History

FinTrust Capital Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-356	Closed	-$2K	–	1270
2021 Q3	$2K	Hold	356	–	–	﹤0.01%	1115
2021 Q2	$2K	Hold	356	–	–	﹤0.01%	1132
2021 Q1	$3K	Hold	356	–	–	﹤0.01%	1079
2020 Q4	$2K	Hold	356	–	–	﹤0.01%	1032
2020 Q3	$1	Hold	356	–	–	﹤0.01%	1124
2020 Q2	$2K	Sell	356 -387	-52%	-$1.65K	﹤0.01%	980
2020 Q1	$3K	Hold	743	–	–	﹤0.01%	976
2019 Q4	$4K	Hold	743	–	–	﹤0.01%	918
2019 Q3	$2K	Hold	743	–	–	﹤0.01%	1009
2019 Q2	$2K	Hold	743	–	–	﹤0.01%	978
2019 Q1	$2K	Hold	743	–	–	﹤0.01%	1141
2018 Q4	$4K	Buy	+743	New	+$4.51K	﹤0.01%	1011

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FinTrust Capital Advisors's IMGN Position: Q4 2021 in Review

FinTrust Capital Advisors sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 356 shares — an estimated $2K sold.

FinTrust Capital Advisors first reported a position in IMGN in Q4 2018 and held it in 12 quarters. The position peaked at $4K in Q4 2019. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

FinTrust Capital Advisors reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
FinTrust Capital Advisors sold 356 Immunogen Inc shares in Q4 2021, an estimated $2K.
FinTrust Capital Advisors first reported a position in Immunogen Inc in Q4 2018 and held it in 12 quarters.
FinTrust Capital Advisors's Immunogen Inc position peaked at $4K in Q4 2019.
236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on FinTrust Capital Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.